Completed OBSERVATIONAL NCT02811705

Life Quality Study for PFAPA Patient (PFAPA)

Sponsor: Versailles Hospital

Updated 8 times since 2017 Last updated: Feb 6, 2023 Started: Jul 31, 2015 Primary completion: Dec 31, 2016 Completion: Apr 30, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates PFAPA Syndrome and is currently completed. Versailles Hospital leads this study, which shows 8 recorded versions since 2015 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Mar 2023 — Jul 2024 [monthly]

Completed

Status: Unknown Status → Completed
Jan 2021 — Mar 2023 [monthly]

Unknown Status
Jul 2018 — Jan 2021 [monthly]

Unknown Status

Status: Recruiting → Unknown Status

▶ Show 3 earlier versions

Jun 2018 — Jul 2018 [monthly]

Recruiting
Apr 2018 — Jun 2018 [monthly]

Recruiting

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Recruiting NA

First recorded

Jul 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Versailles Hospital

Data source: Versailles Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Le Chesnay, France
• Paris, France